Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
471 Leser
Artikel bewerten:
(0)

Founding of WAIDID, the World Association for Infectious Diseases and Immunological Disorders Unveiled at the Infectious Diseases World Summit Shanghai 5-6 July 2014

MILAN, July 7, 2014 /PRNewswire/ --

WAIDID, the newInternational Scientific Societypresided over byProf. Susanna Esposito, has the objective of promoting scientific research and the dissemination of information on infectious and immunological diseases on both the national and international levels while raising public awareness with regard to such diseases, which can prove to be very widespread among both adults and children.

On the international panorama there was no scientific society specialised in infectious and immunological diseases and involving all the different organ specialists who treat children, adults and the elderly.

(Logo: http://photos.prnewswire.com/prnh/20140707/696426-a )

(Photo: http://photos.prnewswire.com/prnh/20140707/696426-b )

"I am pleased to announce the founding of WAIDID,"states Prof. Susanna Esposito, President WAIDID and Director of the Paediatric Intensive Care Unit of the Polyclinic of Milan. "This is the fulfilment of a project I have always believed in, and I am proud to present the new association for the first time at the Respiratory Experts Forum in Shanghai. Our objective is to promote scientific research and the dissemination of information regarding illnesses pertinent to a number of different medical disciplines and which affect all the different age groups, as do infectious and immunological diseases. We will achieve this by developing educational initiatives and on-going professional training meant to benefit all those healthcare professionals involved in the treatment and cure of these pathologies."

The association will soon be on-line with the site http://www.waidid.org, where healthcare professionals, the media and the public will be able to consult information and documentation on infectious and immunological pathologies. Specific consulting on the part of specialists in the field (including pulmonologists, rheumatologists, gastroenterologists and renal experts) and by physicians specialised in the treatment of the different age groups (neonatologists, paediatricians, internists and gerontologists) will be available, plus major international events and news of the principal scientific news in the field.

The international debut of WAIDID occurred on the occasion of the Respiratory Experts Forum in Shanghai, which reached its conclusion yesterday, having been attended by all the top international experts at Infectious Diseases, who gathered to discuss new developments and breakthroughs in the field of recurrent respiratory infections (RRI) and their prevention.

The first WAIDID congress will be held in 2016 in Milan (site of the association's headquarters), bringing together the leading experts from all over the world.

SOURCE The World Association for Infectious Diseases and Immunological Disorders

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.